Nomination Summary for Elmiron (sodium pentosanpolysulfate) (N87313)

Nominated Substances: Elmiron (sodium pentosanpolysulfate)

Nomination Date: 06/17/1987

Nominator: FDA

Rationale: Drug has orphan drug status in the U.S. for the compassionate treatment of interstitial cystitis under the Food and Drug Administration (FDA) investigational New Drug procedure; potential for chronic use; currently marketed in several foreign countries.

NTP Principles: Pre 1993 - 2

Status: Selected


Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.

Back to Top

CASRN: 37319-17-8

Agent Name: Elmiron (sodium pentosanpolysulfate)